… kinase inhibitor sorafenib (Nexavar).2 In this trial, a … treatment strategies and the European Society for Medical Oncology … FDA's next assessment of the manufacturing remediations … Therapeutics announces FDA acceptance of new drug application resubmission …

… phase 3 CARES-310 trial (NCT03764293), which compared … the combination or sorafenib monotherapy. The treatment regimen for … Therapeutics announces FDA acceptance of New Drug Application resubmission … News release. Jiangsu Hengrui Pharmaceuticals Co Ltd. May 17 …

… recent years, precision biotechnologies represented by optogenetics have … facilitated oral delivery of sorafenib and improved hepatic … microRNA delivery in cancer treatment. Drug Deliv Transl Res. … for improved dermal drug delivery. Pharmaceutics. 2022;14(3 …

… unique curative effect. Traditional Chinese medicine treatment has multi-target, multi- … development of novel targeted drugs or natural drugs. Abbreviations ACC, Acetyl … promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5‐LSD1 …

… cells to treatments, thereby enhancing their drug resistance.6 … biological barriers to drug delivery. Nat Biotechnol. 2015;33( … E, et al. Sorafenib targets the mitochondrial electron … mitochondrial targeting and imaging. Pharmaceutics. 2022;15(1):103. …

… resubmitted a new drug application for rivoceranib, … partner Jiangsu Hengrui Pharmaceuticals resubmitted a biologics license … Bayer’s Nexavar (sorafenib) in unresectable hepatocellular carcinoma … The European Society for Medical Oncology (ESMO) living …

… doctors use tyrosine kinase inhibitors (TKIs). Drugs like Lenvima (lenvatinib) or (Nexavar) sorafenib … a daily hormone pill, known as levothyroxine … there clinical trials available if standard treatments stop … substitute for professional medical advice, as …

… of Medicine, Massachusetts General Hospital, Boston, examined contemporary treatment patterns … treatment patterns for hepatocellular carcinoma shifted markedly over time, with sorafenib … and prospective trials—is needed to refine treatment sequencing …

… docetaxel (DTX),57 and sorafenib (SFB)49 frequently featured. … The treatment of breast cancer in the era of precision medicine. … for targeted drug delivery in ovarian cancer. Pharmaceutics. 2025;17 … al. Novel delivery of sorafenib by natural killer cell- …

… assigned to placebo switched to treatment with sorafenib following unblinding due to … argue that the [randomized discontinuation trial] design selects a more indolent … crossed over to the investigational drug after unblinding enabled an ethically …